Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Studies of potential cerebrospinal fluid molecular markers for Alzheimer's disease

1 Jul 2002

Abstract excerpt

There is a need for a reliable, molecular-based ante mortem diagnostic test for Alzheimer's disease (AD). In this study, we examined the use of two-dimensional protein electrophoresis for generating molecular barcodes which may be useful for the clinical differentiation of AD patients from normals. We compared cerebrospinal fluid samples taken from AD patients with confirmed post mortem pathology to comparable...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Proteomics Techniques and Applications
Share to Alzheimer's disease research and treatments
Share to Metabolomics and Mass Spectrometry Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 12210229
DOI: 10.1002/1522-2683(200207)23:14<2247::aid-elps2247>3.0.co;2-m

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Studies of potential cerebrospinal fluid molecular markers for Alzheimer's diseasePMID 12210229Read ↗

A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer’s disease pathologySemantic proximity Read ↗

Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomicsSemantic proximity Read ↗

Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomicsSemantic proximity Read ↗

Large-scale cerebrospinal fluid proteomic analysis in Alzheimer’s disease patients reveals five molecular subtypes with distinct genetic risk profilesSemantic proximity Read ↗

Alzheimer’s disease CSF biomarkers correlate with early pathology and alterations in neuronal and glial gene expressionSemantic proximity Read ↗

Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's diseaseSemantic proximity Read ↗

Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's diseaseSemantic proximity Read ↗

Multiplex cerebrospinal fluid proteomics identifies biomarkers for diagnosis and prediction of Alzheimer’s diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.